Table 3.
Levels of anthropometric, haematological, and lipid indicators according to the hyperhomocysteinemia (HHcy) criteria.
| Parameters | Female |
Male |
|||||
|---|---|---|---|---|---|---|---|
| Hcy (μmol L–1) | |||||||
| N = 224 < 15.0 |
N = 16 > 15.0 |
P-value | N = 88 < 15.0 |
N = 20 > 15.0 |
P-value | ||
| BMI (kg m–2) | 24.3 (21.4, 28.0) | 30.5 (24.9, 32.0) | 0.049 | 23.7 (21.2, 24.3) | 21.0 (19.0, 25.5) | 0.655 | |
| Body fat (%) | 38.2 (31.9, 43.4) | 43.3 (38.1, 48.9) | 0.087 | 20.4 (15.6, 25.2) | 15.4 (14.2, 28.5) | 0.796 | |
| Visceral fat (%) | 4.0 (3.0, 5.5) | 6.0 (5.0, 6.5) | 0.033 | 4.8 (3.0, 7.0) | 4.0 (2.0, 8.0) | 0.869 | |
| Skeletal muscle (%) | 25.3 (23.8, 26.8) | 24.4 (22.5, 25.6) | 0.216 | 40.5 (37.0, 43.0) | 41.2 (35.5, 44.6) | 0.869 | |
| Erythrocytes (106 µL–1) | 4.4 (4.2, 4.6) | 4.4 (4.4, 4.5) | 0.626 | 5.0 (5.0, 5.2) | 5.3 (5.2, 5.5) | 0.069 | |
| Haemoglobin (mg dL–1) | 12.7 (12.1, 13.3) | 12.6 (12.4, 13.0) | 0.913 | 15.0 (14.5, 15.2) | 15.6 (14.4, 16.4) | 0.436 | |
| Haematocrit (%) | 36.4 (34.6, 38.3) | 35.9 (35.3, 37.7) | 0.917 | 41.6 (40.8, 43.8) | 43.4 (41.0, 45.2) | 0.285 | |
| MCV (fL) | 82.9 (80.7, 85.6) | 80.9 (80.2, 83.7) | 0.283 | 82.8 (80.4, 86.2) | 82.8 (79.8, 84.9) | 0.655 | |
| MCH (pg) | 28.6 (27.8, 29.5) | 28.3 (27.5, 29.5) | 0.650 | 29.8 (29.0, 30.3) | 29.3 (28.7, 30.4) | 0.588 | |
| RDW-CV (%) | 13.3 (12.9, 13.8) | 13.6 (13.1, 14.1) | 0.594 | 13.5 (13.0, 13.8) | 12.9 (12.8, 13.0) | 0.016 | |
| Leucocytes (103 µL–1) | 7.2 (6.2, 8.4) | 7.2 (5.8, 8.9) | 0.733 | 5.9 (5.2, 7.1) | 6.1 (5.6, 6.9) | 0.796 | |
| Platelets (103 µL–1) | 309.0 (284.0, 351.0) | 369.0 (289.0, 404.0) | 0.133 | 269.5 (237.0, 311.0) | 268.0 (237.0, 324.0) | 0.981 | |
| TC (mg dL–1) | 157.0 (138.0, 177.0) | 156.5 (152.0, 166.0) | 0.929 | 147.0 (130.0, 171.0) | 149.5 (121.0, 172.0) | 0.994 | |
| TG (mg dL–1) | 79.0 (58.0, 108.0) | 73.0 (60.5, 86.0) | 0.669 | 61.0 (52.0, 107.0) | 92.5 (69.0, 113.0) | 0.285 | |
| HDL-C (mg dL–1) | 46.0 (39.0, 53.0) | 47.0 (35.5, 64.5) | 0.703 | 45.0 (38.0, 53.0) | 37.5 (32.0, 43.0) | 0.049 | |
| LDL-C (mg dL–1) | 95.0 (70.0, 117.0) | 104.0 (86.5, 155.0) | 0.222 | 82.0 (68.0, 100.0) | 93.0 (86.0, 124.0) | 0.225 | |
| VLDL-C (mg dL–1) | 15.8 (11.6, 21.6) | 14.6 (12.1, 17.0) | 0.669 | 12.2 (10.4, 21.4) | 18.5 (13.8, 22.6) | 0.285 | |
| TC/HDL ratio | 3.4 (2.9, 4.1) | 3.0 (2.5, 4.4) | 0.545 | 3.08 (2.6, 4.1) | 4.1 (3.9, 4.3) | 0.144 | |
| LDL/HDL ratio | 2.0 (1.5, 2.7) | 2.3 (1.8, 2.8) | 0.364 | 1.78 (1.5, 2.4) | 2.78 (2.6, 3.0) | 0.016 | |
| AIP | –0.12 (−.27, 0.06) | −.26 (−.32, 0.03) | 0.456 | –0.2 (−.29, −.07) | 0.04 (−.06, 0.08) | 0.055 | |
BMI, body mass index; MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; RDW-CV, red cell distribution width; Hcy, homocysteine; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein (HDL) cholesterol; LDL-C, low-density lipoprotein (LDL) cholesterol; VLDL-C, very-low-density lipoprotein (VLDL) cholesterol; AIP, atherogenic index of plasma. Data are presented as median values and interquartile ranges (IR). The Mann–Whitney U-test was employed to compare the distribution between groups. Statistical significance was set at P < 0.05.